Balyasny Asset Management

Balyasny Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Balyasny Asset Management’s Portfolio SRTA Stock Details SRTA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$814K	Buy
2025 Q1	–	Sell
2024 Q4	$62K	Buy
2022 Q4	–	Sell
2022 Q3	$57K	Buy
2022 Q2	–	Sell
2022 Q1	$307K	Buy